Target intelligence / Profile preview

Ubiquitin carboxyl-terminal hydrolase 50 (USP50)

Target
USP50
Molecular classification
Enzyme, Deubiquitinating enzyme (USP family)
01

Overview

Ubiquitin carboxyl-terminal hydrolase 50 (USP50) is a member of the ubiquitin-specific protease (USP) family of deubiquitinating enzymes, though it is classified as a non-protease homolog in humans due to lack of catalytic acidic residues and little or no canonical deubiquitinating activity[1][3][5]. USP50 is a chromatin-associated protein that binds ubiquitin conjugates and is crucial for proper coordination of DNA replication, particularly by promoting correct selection and localization of helicases (notably WRN, RECQL4/5) and nucleases (FEN1, DNA2) at replication forks, supporting ongoing replication, maintaining telomere integrity, and aiding fork restart following genotoxic stress[1][2]. It also has regulatory roles in cell cycle progression (G2/M checkpoint), inflammasome assembly, and IL-1β production[3][5][7]. Loss or dysfunction of USP50 leads to replication stress, telomere instability, and has implications in cancer, premature aging, and hereditary genomic instability disorders[1][2][3]. No specific drugs are reported to directly target USP50 as of current knowledge.

Other names
Ubiquitin-specific peptidase 50USP50Ubiquitin carboxyl-terminal hydrolase 50Ubiquitin specific protease 50UBP50Inactive ubiquitin carboxyl-terminal hydrolase 50Inactive ubiquitin-specific peptidase 50
02

Biological functions

Regulation of the cell cycle (G2/M checkpoint)DNA replication and fork restartTelomere maintenanceRegulation of inflammasome signalingRegulation of interleukin-1 beta productionNuclear speck organization
03

Disease associations

CancerEarly aging syndromesHereditary genomic instability syndromesMachado-Joseph diseaseDuodenogastric reflux
04

Safety considerations

Low tissue expression complicates detectionFunctional redundancy with other USPs may limit drug specificity

Beyond the preview

Go deeper on Ubiquitin carboxyl-terminal hydrolase 50 (USP50).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ubiquitin carboxyl-terminal hydrolase 50 (USP50).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call